Nxera Pharma Co., Ltd.

ISIN JP3431300007

WKN A0B7EK

Market cap (in EUR)

442 m

Country

Japan

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Nxera Pharma Co., Ltd. is a technology powered biopharma company focused on specialty medicines in Japan and globally. The company engages in activities from discovery through to late clinical stage and commercialization, internally and in partnership with global pharma and biotech companies. It focuses on some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders, and rare diseases, and leverages the power of its GPCR targeted structure based drug discovery NxWave platform to provide a source of best- or first-in-class medicines. The company was founded by Shinichi Tamura and Takaya Nakamura on June 22, 1990 and is headquartered in Tokyo, Japan.

Show more Show less

Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan

Chart

Financials

Key metrics

Market capitalisation, EUR	442 m
EPS, EUR	-0.41
P/B ratio	1.2
P/E ratio	70.0
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	176 m
Net income, EUR	-30 m
Profit margin	-16.78%

What ETF is Nxera Pharma Co., Ltd. in?

There are 6 ETFs which contain Nxera Pharma Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Nxera Pharma Co., Ltd. is the iShares MSCI Japan Small Cap UCITS ETF (Dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing	0.01%	Equity Asia Pacific Social/Environmental	26
Amundi MSCI Disruptive Technology UCITS ETF Acc	0.01%	Equity World Technology Social/Environmental Innovation	145
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	Equity World Social/Environmental	495
iShares MSCI Japan Small Cap UCITS ETF (Dist)	0.04%	Equity Japan Small Cap	424
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)	0.01%	Equity Japan	150
Amundi Japan TOPIX II UCITS ETF EUR Hedged Dist	0.01%	Equity Japan	61

Performance

Returns overview

YTD	+6.43%
1 month	+1.48%
3 months	-15.04%
6 months	-3.81%
1 year	-22.33%
3 years	-69.03%
5 years	-68.63%
Since inception (MAX)	-55.76%
2025	-29.31%
2024	-29.89%
2023	-38.93%
2022	+0.00%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).